Non-Hodgkin’s Lymphoma of the synovium discovered in total knee arthroplasty: a case report

BMC Research Notes

Arno M ten Ham¹  Ineke M de Kievit-van der Heijden²  Vincent JJF Busch¹  Jetze Visser¹ 

[1] Sint Maartenskliniek, Department of Orthopaedics, Hengstdal 3, PO Box 9011, 6500GM, Nijmegen, The Netherlands;Canisius Wilhelmina Hospital, Department of Pathology, Nijmegen, The Netherlands

关键词: Rheumatoid arthritis;    Total knee arthroplasty;    Non-Hodgkin's lymphoma;   

Others  :  1165914
DOI  :  10.1186/1756-0500-5-449

 received in 2012-07-12, accepted in 2012-08-14,  发布年份 2012

【 摘 要 】

Background

Musculoskeletal involvement occurs in 25% of patients with non-Hodgkin’s lymphoma (NHL). Primary lymphoma in the joint is rare. It can present as a bone lesion or as atypical soft tissue proliferation. NHL has an increased incidence in patients with autoimmune rheumatic diseases.

Case presentation

We present a case in which non-Hodgkin’s lymphoma was found coincidentally in the synovium during knee joint replacement surgery in a 69-year old woman with rheumatoid arthritis. Pigmented, vitreous tissue was resected, which turned out to be a diffuse large B-cell lymphoma after histological examination. The coincidental intraoperative finding of intra-articular non-Hodgkin’s lymphoma was reported twice before, presenting as synovial proliferation in elbow and shoulder surgery. In a few other cases non-Hodgkin’s lymphoma presented most often in the knee, as a bone lesion or, when soft tissue was involved, as arthritis.

Conclusion

Non-Hodgkin’s lymphoma should be considered in patients with autoimmune rheumatic diseases. In case of persistent arthritis, non-respondent to anti-inflammatory drugs, a biopsy might be warranted. Moreover, when arthroscopy or arthrotomy is planned, any atypical tissue should be sent for histological analysis. Early diagnosis of NHL can contribute to improved outcome of its rapidly developing treatment options.

【 授权许可】

   
2012 Visser et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Dorfman HD, Siegel HL, Perry MC, Oxenhandler R: Non-Hodgkin's lymphoma of the synovium simulating rheumatoid arthritis. Arthritis Rheum 1987, 30:155-161.
• [2]Jawa A, Lieberman AE, Alexieva CC, Jupiter JB: Primary intra-articular non-Hodgkin's lymphoma of the elbow. A case report. J Bone Joint Surg Am 2006, 88:2730-2734.
• [3]Mileti J, Mileti L, Kaeding C: Non-Hodgkin's lymphoma of the knee diagnosed by arthroscopy. Arthroscopy 2007, 23:447. e441-444
• [4]Vadivelu R, Kar N, Margetts MJ, Abdul-Cader AH: Non-Hodgkin's lymphoma as an unexpected diagnosis in a hip arthroplasty. Arch Orthop Trauma Surg 2002, 122:532-534.
• [5]Watson AJ, Cross MJ: Non-Hodgkin lymphoma as an unexpected diagnosis after elective total knee arthroplasty. J Arthroplasty 2008, 23:612-614.
• [6]Zwitser EW, de Gast A, Basie MJ, van Kemenade FJ, van Royen BJ: B-cell lymphoma in retrieved femoral heads: a long term follow up. BMC Musculoskelet Disord 2009, 10:53. BioMed Central Full Text
• [7]Arredondo J, Worland RL, Sinnenberg RJ Jr, Qureshi GD: Non-Hodgkin's lymphoma as an unexpected diagnosis in a shoulder arthroplasty. J Arthroplasty 1999, 14:108-111.
• [8]Ikeda J, Morii E, Yamauchi A, Kohara M, Hashimoto N, Yoshikawa H, Iwasaki M, Aozasa K: Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type developing in gonarthritis deformans. J Clin Oncol 2007, 25:4310-4312.
• [9]Starkebaum G: Rheumatoid arthritis, methotrexate, and lymphoma: risk substitution, or cat and mouse with Epstein-Barr virus? J Rheumatol 2001, 28:2573-2575.
• [10]Dias C, Isenberg DA: Susceptibility of patients with rheumatic diseases to B-cell non-Hodgkin lymphoma. Nat Rev Rheumatol 2011, 7:360-368.
• [11]Baecklund E, Iliadou A, Askling J, Ekbom A, Backlin C, Granath F, Catrina AI, Rosenquist R, Feltelius N, Sundstrom C, Klareskog L: Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum 2006, 54:692-701.
• [12]Flowers CR, Armitage JO: A decade of progress in lymphoma: advances and continuing challenges. Clin Lymphoma Myeloma Leuk 2010, 10:414-423.